AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1687238 — intervention group
Group type: EXPERIMENTAL
Intervention: Mequitazine (MQZ) 5 mg BID for 7 days
Number of subjects: 29
Study 1687238 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline or histamine prick test)
Number of subjects: 29
Study 6364621 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg phenylethylamine in apple juice
Number of subjects: 47
Study 6364621 — intervention group
Group type: EXPERIMENTAL
Intervention: Four different wines (2 dl) containing biogenic amines
Number of subjects: 47
Study 6364621 — intervention group
Group type: COMPARATOR
Intervention: 25 mg histamine in apple juice
Number of subjects: 47
Study 6364621 — intervention group
Group type: COMPARATOR
Intervention: 25 mg tyramine in apple juice
Number of subjects: 47
Study 30251255 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect calorimetry (IC)
Number of subjects: 40
Study 30251255 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 40
Study 31748594 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (145 mg tablet) administered once daily for 2 months (Mo2)
Number of subjects: 18
Study 31748594 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (145 mg tablet) administered once daily for 4 months (Mo4)
Number of subjects: 18
Study 31748594 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 18
Study 27913736 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (1g in 100mL normal saline during sternal closure)
Number of subjects: 82
Study 27913736 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tranexamic acid
Number of subjects: 82
Study 25958710 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl at 1 mcg/kg/dose
Number of subjects: 55
Study 25958710 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ketamine at 1 mg/kg/dose
Number of subjects: 55
Study 23239489 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-length, wedged insole
Number of subjects: 14
Study 21969011 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure-time physical activity (increased from <5 to >5 MET h/wk or >30 MET h/wk)
Number of subjects: 553
Study 21969011 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistently active adolescents
Number of subjects: 553
Study 21969011 — intervention group
Group type: COMPARATOR
Intervention: Sedentary adolescents
Number of subjects: 553
Study 19635277 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinzaparin 175 IU/kg subcutaneously once daily for 12 weeks
Number of subjects: 480
Study 19635277 — intervention group
Group type: COMPARATOR
Intervention: Usual care (tinzaparin for >or=5 days plus oral warfarin for >or=12 weeks)
Number of subjects: 480
Study 19635277 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinzaparin
Number of subjects: 480
Study 16631323 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 4.0 mg
Number of subjects: 63
Study 16631323 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 1.0 mg
Number of subjects: 63
Study 16631323 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 63
Study 14983506 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral risk factor reduction interventions in older adults
Number of subjects: 1247
Study 14983506 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related vulnerability factors
Number of subjects: 1247
Study 14983506 — intervention group
Group type: EXPERIMENTAL
Intervention: Comorbid conditions and social support
Number of subjects: 1247
Study 11529585 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved glycaemic control (IC)
Number of subjects: 43
Study 11529585 — intervention group
Group type: COMPARATOR
Intervention: Usual glycaemic control (UC)
Number of subjects: 43
Study 9778323 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy (aspirin and ticlopidine)
Number of subjects: 485
Study 9778323 — intervention group
Group type: COMPARATOR
Intervention: Conventional anticoagulation (heparin or oral anticoagulant)
Number of subjects: 485
Study 7513534 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose aprotinin
Number of subjects: 0
Study 7513534 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 3351175 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone support system (regular calls by a public health nurse, available to call nurse every weekday during normal working hours)
Number of subjects: 182
Study 3351175 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 182
Study 31360880 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern
Number of subjects: 48835
Study 31360880 — intervention group
Group type: COMPARATOR
Intervention: Usual diet comparison group
Number of subjects: 48835
Study 27159397 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mcg vaccine
Number of subjects: 240
Study 27159397 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mcg vaccine
Number of subjects: 240
Study 27159397 — intervention group
Group type: COMPARATOR
Intervention: Both 15 mcg and 30 mcg vaccines
Number of subjects: 240
Study 24717011 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group receiving counselling sessions based on social cognitive theory and motivational interviewing starting at 8-9 months of age and ending at age 4
Number of subjects: 1369
Study 24717011 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving regular services without the intervention
Number of subjects: 1369
Study 23178540 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-minute duration of wheelchair tilt-in-space and recline
Number of subjects: 9
Study 23178540 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-minute duration of wheelchair tilt-in-space and recline
Number of subjects: 9
Study 23178540 — intervention group
Group type: EXPERIMENTAL
Intervention: 0-minute duration of wheelchair tilt-in-space and recline
Number of subjects: 9
Study 21551462 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 50 mg
Number of subjects: 1861
Study 21551462 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 75 mg
Number of subjects: 1861
Study 21551462 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg
Number of subjects: 1861
Study 21551462 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg
Number of subjects: 1861
Study 21551462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1861
Study 18481718 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture with pushing manipulation
Number of subjects: 80
Study 18481718 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 80
Study 16252079 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent application
Number of subjects: 51
Study 16252079 — intervention group
Group type: COMPARATOR
Intervention: PTA (Percutaneous Transluminal Angioplasty)
Number of subjects: 51
Study 12674333 — intervention group
Group type: EXPERIMENTAL
Intervention: MTHFR TT genotype
Number of subjects: 1748
Study 12674333 — intervention group
Group type: COMPARATOR
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 1748
Study 11104182 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive preparation prior to video feedback
Number of subjects: 0
Study 11104182 — intervention group
Group type: COMPARATOR
Intervention: No cognitive preparation (Control)
Number of subjects: 0
Study 8931348 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD)
Number of subjects: 17
Study 8931348 — intervention group
Group type: COMPARATOR
Intervention: Control group (467 healthy controls)
Number of subjects: 17
Study 1364968 — intervention group
Group type: EXPERIMENTAL
Intervention: Olimunostim (7 consecutive daily doses, perorally)
Number of subjects: 16
Study 1364968 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 16
Study 7372036 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment groups (individual-oriented intervention for high-risk subjects and mass health education for the remaining 70%)
Number of subjects: 6000
Study 7372036 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment groups (high-risk subgroups)
Number of subjects: 6000
Study 7372036 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment groups (random population)
Number of subjects: 6000
Study 7372036 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment groups (whole treatment populations)
Number of subjects: 6000
Study 7372036 — intervention group
Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 6000
Study 7372036 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment groups
Number of subjects: 6000
Study 30864474 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA)
Number of subjects: 289
Study 27826781 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D laparoscopic surgery
Number of subjects: 221
Study 27826781 — intervention group
Group type: COMPARATOR
Intervention: 2D laparoscopic surgery
Number of subjects: 221
Study 24798710 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended Intervention (EI)
Number of subjects: 205
Study 24798710 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic Intervention (BI)
Number of subjects: 205
Study 24798710 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 205
Study 22907790 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 ml daily of 100% Concord grape juice
Number of subjects: 113
Study 22907790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study 20921939 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir (ETV)
Number of subjects: 57
Study 20921939 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV)
Number of subjects: 57
Study 20921939 — intervention group
Group type: COMPARATOR
Intervention: Both ETV and ADV
Number of subjects: 57
Study 19893995 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine
Number of subjects: 985
Study 17300239 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified creams
Number of subjects: 78
Study 17300239 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-free gel
Number of subjects: 78
Study 17300239 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinary cream (5% urea)
Number of subjects: 78
Study 17300239 — intervention group
Group type: EXPERIMENTAL
Intervention: One of the simplified creams
Number of subjects: 78
Study 17300239 — intervention group
Group type: COMPARATOR
Intervention: All test preparations
Number of subjects: 78
Study 16624688 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg/kg intravenously, equivalent to 2 cups of coffee)
Number of subjects: 10
Study 16624688 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 10
Study 12515871 — intervention group
Group type: COMPARATOR
Intervention: Cold Pressor Test (CPT)
Number of subjects: 20
Study 12515871 — intervention group
Group type: COMPARATOR
Intervention: Dipyridamole infusion
Number of subjects: 20
Study 12515871 — intervention group
Group type: COMPARATOR
Intervention: ACE-inhibitor infusion during CPT
Number of subjects: 20
Study 12515871 — intervention group
Group type: COMPARATOR
Intervention: ACE-inhibitor infusion after dipyridamole
Number of subjects: 20
Study 10428524 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 47
Study 10428524 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 47
Study 7779148 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 18
Study 7779148 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 18
Study 7779148 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine clonixinate
Number of subjects: 18
Study 1692687 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg propranolol (beta-blocker)
Number of subjects: 9
Study 1692687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 7025784 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride; treatment duration: three-week treatment periods.
Number of subjects: 0
Study 7025784 — intervention group
Group type: COMPARATOR
Intervention: Placebo; treatment duration: three-week treatment periods.
Number of subjects: 0
Study 29913108 — intervention group
Group type: EXPERIMENTAL
Intervention: Childcare-based intervention to reduce sitting time
Number of subjects: 115
Study 29913108 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 115
Study 29913108 — intervention group
Group type: EXPERIMENTAL
Intervention: Childcare-based intervention
Number of subjects: 115
Study 29354990 — intervention group
Group type: EXPERIMENTAL
Intervention: Alliance therapy group with scalp acupuncture, music therapy and rehabilitation
Number of subjects: 76
Study 29354990 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group with music therapy and rehabilitation
Number of subjects: 76
Study 29354990 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation group
Number of subjects: 76
Study 25430812 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 75 mg orally twice daily for 2 weeks starting on the day of surgery
Number of subjects: 68
Study 25430812 — intervention group
Group type: COMPARATOR
Intervention: Loxoprofen orally three times daily for 2 weeks starting on the day of surgery
Number of subjects: 68
Study 23417203 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportional Assist Ventilation with load adjustable gain factors (PAV+)
Number of subjects: 14
Study 23417203 — intervention group
Group type: COMPARATOR
Intervention: Pressure Support Ventilation (PSV)
Number of subjects: 14
Study 21793297 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency denervation of facet joints
Number of subjects: 42
Study 21793297 — intervention group
Group type: COMPARATOR
Intervention: Control group (no spinal surgery)
Number of subjects: 42
Study 18854804 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (9 patients) with positive notching at week 20 and 24 in both pregnancies
Number of subjects: 14
Study 18854804 — intervention group
Group type: COMPARATOR
Intervention: Group B (5 patients) with bilateral positive notching at week 20 and 24 only in the second pregnancy
Number of subjects: 14
Study 16783500 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem solving training (n = 32)
Number of subjects: 63
Study 16783500 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 31)
Number of subjects: 63
Study 12553384 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 150 mg diluted in 60 mL NaCl 0.9%
Number of subjects: 0
Study 12553384 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 150 mg diluted in 30 mL NaCl 0.9%
Number of subjects: 0
Study 12553384 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 150 mg diluted in 40 mL NaCl 0.9%
Number of subjects: 0
Study 11008909 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 28
Study 8866390 — intervention group
Group type: EXPERIMENTAL
Intervention: MgSO4
Number of subjects: 50
Study 1355211 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical symptoms group (n=572)
Number of subjects: 572
Study 1355211 — intervention group
Group type: COMPARATOR
Intervention: Typical symptoms group (n=2555)
Number of subjects: 572
Study 6228080 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycosaminoglycan polysulfate (GAGPS, Arteparon)
Number of subjects: 140
Study 6228080 — intervention group
Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 140
Study 31927702 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine therapy
Number of subjects: 20
Study 31770012 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane 0.6 MAC (Group D1)
Number of subjects: 60
Study 31770012 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane 1.3 MAC (Group D2)
Number of subjects: 60
Study 31770012 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane 2.0 MAC (Group D3)
Number of subjects: 60
Study 31770012 — intervention group
Group type: COMPARATOR
Intervention: Control (before inhalation, T1)
Number of subjects: 60
Study 28318848 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physiotherapy in addition to a home exercise program
Number of subjects: 41
Study 28318848 — intervention group
Group type: COMPARATOR
Intervention: Self-directed home exercise program
Number of subjects: 41
Study 28318848 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Supervised physiotherapy and Self-directed home exercise)
Number of subjects: 41
Study 27058481 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior-therapy anxiety-management (work-anxiety coping group, WAG)
Number of subjects: 345
Study 27058481 — intervention group
Group type: COMPARATOR
Intervention: Recreational activities (RG)
Number of subjects: 345
Study 25233569 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure
Number of subjects: 42
Study 25233569 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure and topical anesthetic (20% benzocaine)
Number of subjects: 42
Study 25233569 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure and cold (TFE)
Number of subjects: 42
Study 25233569 — intervention group
Group type: COMPARATOR
Intervention: Control (no concurrent stimulation)
Number of subjects: 42
Study 22234244 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB) 1.25 mg
Number of subjects: 150
Study 22234244 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB) 1.25 mg and intravitreal triamcinolone acetonide (IVT) 2 mg
Number of subjects: 150
Study 22234244 — intervention group
Group type: COMPARATOR
Intervention: Macular laser photocoagulation (MPC)
Number of subjects: 150
Study 19515102 — intervention group
Group type: EXPERIMENTAL
Intervention: DVD delivery of falls prevention education
Number of subjects: 100
Study 19515102 — intervention group
Group type: EXPERIMENTAL
Intervention: Workbook delivery of falls prevention education
Number of subjects: 100
Study 19515102 — intervention group
Group type: EXPERIMENTAL
Intervention: Either DVD or workbook education
Number of subjects: 100
Study 19515102 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 100
Study 17328356 — intervention group
Group type: EXPERIMENTAL
Intervention: Positron emission tomography (PET) using the tracer 11C-methionine
Number of subjects: 0
Study 17328356 — intervention group
Group type: COMPARATOR
Intervention: Immediate radiotherapy
Number of subjects: 0
Study 17328356 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 0
Study 15229206 — intervention group
Group type: EXPERIMENTAL
Intervention: Drospirenone oral contraceptive (OC)
Number of subjects: 29
Study 11409067 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adhesive breast prosthesis
Number of subjects: 101
Study 11409067 — intervention group
Group type: COMPARATOR
Intervention: Traditional external breast prosthesis
Number of subjects: 101
Study 9236408 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombomodulin gene mutations (GG‐9/‐10AT, G‐33A, C‐133A)
Number of subjects: 104
Study 9236408 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (matched for age, sex, and race)
Number of subjects: 104
Study 9236408 — intervention group
Group type: EXPERIMENTAL
Intervention: Previously identified neutral polymorphism GCC/GTC coding for Ala/Val455
Number of subjects: 104
Study 8138330 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (4 mg/l mixed into the cardioplegic solution)
Number of subjects: 54
Study 8138330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 3315268 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release theophylline (mean 11.2 mg/kg per day)
Number of subjects: 19
Study 3315268 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release theophylline
Number of subjects: 19
Study 3315268 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release terbutaline (mean 0.25 mg/kg per day)
Number of subjects: 19
Study 29366658 — intervention group
Group type: EXPERIMENTAL
Intervention: Only clinical data (OCD)
Number of subjects: 76
Study 29366658 — intervention group
Group type: EXPERIMENTAL
Intervention: Only lung ultrasound data (OLD)
Number of subjects: 76
Study 29366658 — intervention group
Group type: EXPERIMENTAL
Intervention: Both clinical and lung ultrasound data
Number of subjects: 76
Study 27282133 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamaldehyde (20 mg)
Number of subjects: 22
Study 27282133 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (4 mg)
Number of subjects: 22
Study 27282133 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cinnamaldehyde and nicotine
Number of subjects: 22
Study 27282133 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamaldehyde responders
Number of subjects: 22
Study 24722774 — intervention group
Group type: EXPERIMENTAL
Intervention: tenofovir-emtricitabine
Number of subjects: 254
Study 24722774 — intervention group
Group type: COMPARATOR
Intervention: abacavir-lamivudine
Number of subjects: 254
Study 24419925 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg and Tadalafil 5 mg
Number of subjects: 165
Study 24419925 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg
Number of subjects: 165
Study 24419925 — intervention group
Group type: COMPARATOR
Intervention: Tadalafil 5 mg
Number of subjects: 165
Study 21415582 — intervention group
Group type: EXPERIMENTAL
Intervention: TACE-surgery group
Number of subjects: 32
Study 21415582 — intervention group
Group type: COMPARATOR
Intervention: Surgery group
Number of subjects: 32
Study 19083404 — intervention group
Group type: EXPERIMENTAL
Intervention: Purple passion fruit peel extract (150 mg/d)
Number of subjects: 0
Study 19083404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16670244 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention with a depression care manager for one year
Number of subjects: 1684
Study 16670244 — intervention group
Group type: COMPARATOR
Intervention: Usual care for one year
Number of subjects: 1684
Study 16670244 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive decline over two years
Number of subjects: 1684
Study 14617058 — intervention group
Group type: EXPERIMENTAL
Intervention: Programme with ankle disc and functional strength training
Number of subjects: 16